Moderna says its RSV shot is 50% effective after 18 months
In their clinical trials, GSK’s RSV vaccine Arexvy was 78% effective in preventing severe RSV over a second year and Pfizer’s was 78% effective midway through a second RSV season.
—————
Boost Internet Speed–
Free Business Hosting–
Free Email Account–
Dropcatch–
Free Secure Email–
Secure Email–
Cheap VOIP Calls–
Free Hosting–
Boost Inflight Wifi–
Premium Domains–
Free Domains
